ABAMETAPIR - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for abametapir and what is the scope of freedom to operate?
Abametapir
is the generic ingredient in one branded drug marketed by Hatchtech and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.Abametapir has thirty-five patent family members in fifteen countries.
One supplier is listed for this compound.
Summary for ABAMETAPIR
| International Patents: | 35 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 112 |
| Clinical Trials: | 6 |
| Patent Applications: | 489 |
| What excipients (inactive ingredients) are in ABAMETAPIR? | ABAMETAPIR excipients list |
| DailyMed Link: | ABAMETAPIR at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for ABAMETAPIR
Generic Entry Date for ABAMETAPIR*:
Constraining patent/regulatory exclusivity:
Dosage:
LOTION;TOPICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for ABAMETAPIR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hatchtech Pty Ltd | Phase 2 |
| Dr. Reddy's Laboratories Limited | Phase 2 |
| Accelovance | Phase 3 |
US Patents and Regulatory Information for ABAMETAPIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ABAMETAPIR
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Poland | 2457582 | ⤷ Try a Trial | |
| World Intellectual Property Organization (WIPO) | 2005007188 | ⤷ Try a Trial | |
| China | 101810613 | Prevention and cure method for ectoparasite and compounds thereof | ⤷ Try a Trial |
| Hong Kong | 1169045 | 用於控制體外寄生蟲的方法和組合物 (METHOD AND COMPOSITIONS FOR CONTROLLING ECTOPARASITES) | ⤷ Try a Trial |
| Australia | 2014377875 | Pediculicidal composition | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
